TrianglePUBLICATIONS · 24642247
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Hematol Oncol
- Publication date
- 2014 Mar 19
- First author
- Bartlett NL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bartlett NL
- type
- Author
- name
- Chen R
- type
- Author
- name
- Fanale MA
- type
- Author
- name
- Brice P
- type
- Author
- name
- Gopal A
- type
- Author
- name
- Smith SE
- type
- Author
- name
- Advani R
- type
- Author
- name
- Matous JV
- type
- Author
- name
- Ramchandren R
- type
- Author
- name
- Rosenblatt JD
- type
- Author
- name
- Huebner D
- type
- Author
- name
- Levine P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bartlett NL
- type
- Author
- name
- Chen R
- type
- Author
- name
- Fanale MA
- type
- Author
- name
- Brice P
- type
- Author
- name
- Gopal A
- type
- Author
- name
- Smith SE
- type
- Author
- name
- Advani R
- type
- Author
- name
- Matous JV
- type
- Author
- name
- Ramchandren R
- type
- Author
- name
- Rosenblatt JD
- type
- Author
- name
- Huebner D
- type
- Author
- name
- Levine P
- type
- Author
- bibliography ids
- nci-bib-c832ce76cf0f7a2fbb071ce8
- book metadata
- content sha256
- 0dd596a2a3e28e1cea61abe61f1f7f895a8bb7c86d7d0a5c8851eeca51a24fb3
- document type
- citation
- dois
- 10.1186/1756-8722-7-24
- electronic publication date
- display
- 2014 Mar 19
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24642247
- immutable id
- pubmed:24642247@0dd596a2a3e28e1cea61abe61f1f7f895a8bb7c86d7d0a5c8851eeca51a24fb3
- journal
- abbreviation
- J Hematol Oncol
- issn electronic
- 1756-8722
- issn print
- Source null
- issue
- Source null
- name
- Journal of hematology & oncology
- nlm unique id
- 101468937
- pages
- 24
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24642247
- provenance
- batch id
- 063b6c38419f18d4021f
- provider
- NCBI PubMed ESummary
- record sha256
- 7bde8b97a18fc6c3964d377e2508aac7ac76d19bef4203f7bc8b8564c15b7f1e
- response sha256
- 5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
- retrieved at
- 2026-09-09T23:47:02.607425+00:00
- publication date
- display
- 2014 Mar 19
- precision
- day
- year
- 2014
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies.
Preserved source evidence · Not medical advice